JANX
Janux Therapeutics, Inc.NASDAQHealthcare$14.84+2.27%ClosedMarket Cap: $902.7M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
14
Sales
6
Buy/Sell Ratio
2.33
Total Bought
$0.00
Total Sold
$6.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Feb 04 | Go William | officer: Chief Medical Officer | Sell | 154,000 | $13.99 | 154,000 |
| Wed Feb 04 | Go William | officer: Chief Medical Officer | Sell | 44,000 | $0.00 | 44,000 |
| Wed Feb 04 | Go William | Sell | 0 | $0.00 | 0 | |
| Fri Jan 02 | Meyer Andrew Hollman | officer: Chief Business Officer | Sell | 1,879 | $13.73 | 83,095 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 31,400 | $0.00 | 155,825 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 2,505 | $13.73 | 124,425 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 109,900 | $13.65 | 109,900 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 96,600 | $0.00 | 381,582 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 338,100 | $13.65 | 338,100 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 8,072 | $13.73 | 284,982 |